Temazepam Administration via Nasogastric Tube
Temazepam capsules should NOT be administered via nasogastric tube as the FDA labeling does not provide guidance for this route, and the capsule formulation is not designed for crushing or tube administration.
Key Considerations
Formulation Limitations
Temazepam is available as a capsule formulation containing a gel-filled liquid 1. The FDA labeling provides no instructions for administration via enteral feeding tubes, and there is no evidence supporting the safety or efficacy of this practice. Unlike some medications that have been studied for NG tube administration, temazepam lacks:
- Validated crushing or opening protocols
- Bioavailability data for tube administration
- Stability data when exposed to water or other diluents
General Principles for Drug Administration via NG Tube
When medications must be given via NG tube, ESPEN guidelines provide clear protocols 2, 3:
Standard Administration Protocol:
- Flush the tube with 30 mL of water before drug administration 2, 3
- Administer each drug individually (never mix medications) 2, 3
- Flush with 30 mL of water between each drug 3
- Flush with 30 mL of water after the final drug 2, 3
- Use appropriate ENFit syringes to prevent misconnection errors 2, 3
Critical Safety Issues
Pharmacist consultation is mandatory before administering any medication via NG tube 3. The pharmacist should:
- Confirm appropriateness of the drug for tube administration
- Identify alternative formulations (liquid, orally disintegrating tablets)
- Assess potential drug-tube interactions
- Evaluate drug-enteral formula interactions 2, 3
Site of delivery matters: Gastric administration may yield different bioavailability than post-pyloric administration 3. Temazepam's absorption profile is optimized for intact capsule delivery to the stomach 1.
Practical Alternatives
Consider these options instead:
- Alternative benzodiazepines with liquid formulations or documented tube administration protocols
- Midazolam - available in liquid form and has established pharmacokinetics 4
- Lorazepam - available in concentrated oral solution
- Consult pharmacy for extemporaneous liquid preparation if temazepam is absolutely required
Common Pitfalls to Avoid
- Never crush medications without explicit guidance - this creates exposure risks and dosing inaccuracies 3
- Never mix multiple medications before tube administration - risk of drug-drug interactions and tube occlusion 3
- Never use inadequate flushing volumes - minimum 30 mL is required to prevent tube occlusion 2, 3
- Never assume oral bioavailability equals NG tube bioavailability - research shows significantly decreased bioavailability in the postoperative period 5
Documentation Requirements
When using unlicensed administration routes, prescribers must accept additional responsibility for adverse events 3. This includes:
- Documenting rationale for tube administration
- Confirming no suitable alternatives exist
- Obtaining informed consent when possible
- Monitoring for therapeutic failure or adverse effects
The safest approach is to select an alternative sedative-hypnotic with established NG tube administration protocols rather than attempting off-label temazepam administration via this route.